Toripalimab combined with nab-paclitaxel/gemcitabine as first-line treatment for advanced pancreatic adenocarcinoma: Updated results of a phase Ib/II clinical study ...
Technological advances in artificial intelligence and humanoid robotics are opening up new potential for commercial applications. In parallel, requirements for efficiency, scalability, and ...
SAN FRANCISCO--(BUSINESS WIRE)--Spotlight Therapeutics, Inc. (“Spotlight”), a biotechnology company applying new insights to develop cell-targeted in vivo CRISPR gene editing biologics, today ...
Andrea Kasinski, Purdue Institute for Cancer Research (PICR) deputy director and professor of biological sciences in Purdue’s College of Science, has been awarded a competitive translational grant ...
– Grant Supports Continued Clinical Development of the Company’s PTM-101 Product and its Potential for Direct Treatment of Pancreatic Cancer – WATERTOWN, Mass.--(BUSINESS WIRE)--PanTher Therapeutics ( ...
CARLSBAD, Calif., Dec. 07, 2022 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (“Qualigen” or “the Company,” Nasdaq: QLGN), a diversified life sciences company focused on developing treatments for ...
New Devices Offer Plethora of Communications Options, Capacitive Touch Interface, and Dual-Bank Flash for Software Updates Renesas Electronics Corporation (TSE:6723), a premier supplier of advanced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback